Co-Diagnostics Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Co-Diagnostics (CODX) Tops Q1 EPS by 4c, Offers Q2 Guidance
May 13, 2021 4:36 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q1 EPS of $0.26, $0.04 better than the analyst estimate of $0.22. Revenue for the quarter came in at $20 million versus the consensus estimate of $19.89 million.
GUIDANCE:
Co-Diagnostics sees Q2 2021 EPS of $0.19-$0.23, versus the consensus of $0.22. Co-Diagnostics sees... More
